Premium
Radiofrequency Ablation of Drug‐Resistant Cancer Cells Using Molecularly Targeted Carboxyl‐Functionalized Biodegradable Graphene
Author(s) -
Sasidharan Abhilash,
Sivaram Amal J.,
Retnakumari Archana P.,
Chandran Parwathy,
Malarvizhi Giridharan Loghanathan,
Nair Shantikumar,
Koyakutty Manzoor
Publication year - 2015
Publication title -
advanced healthcare materials
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.288
H-Index - 90
eISSN - 2192-2659
pISSN - 2192-2640
DOI - 10.1002/adhm.201400670
Subject(s) - graphene , materials science , nanotechnology , conjugated system , drug delivery , targeted drug delivery , drug , nanoparticle , radiofrequency ablation , computer science , ablation , cancer research , medicine , pharmacology , polymer , composite material
Under ultralow radiofrequency (RF) power , transferrin‐conjugated graphene nanoparticles can thermally ablate drug‐ or radiation‐resistant cancer cells very effectively. The results suggest that graphene‐based RF hyperthermia can be an efficient method to manage drug‐/radiation‐resistant cancers.